<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82165">
  <stage>Registered</stage>
  <submitdate>18/08/2007</submitdate>
  <approvaldate>24/09/2007</approvaldate>
  <actrnumber>ACTRN12607000490471</actrnumber>
  <trial_identification>
    <studytitle>Upper airways resistance in obstructive sleep apnoea at simulated altitude</studytitle>
    <scientifictitle>Human voluteer study; Does sleep at simulated high altitude alter upper airway resistance in people with obstructive sleep apnoea?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Obstructive and Central Sleep Anpoea</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Overnight sleep for more than six hours at sea level and at simulated altitude of 2750m. The two study nights are separated by at least one week.</interventions>
    <comparator>Sleep at sea level</comparator>
    <control>Placebo</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Upper airway resistance</outcome>
      <timepoint>Resistence is measured prior to all apnoeas and hypopnoeas during each study night</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Pattern of breathing during periods of supplemental Oxygen and Carbon Dioxide</outcome>
      <timepoint>During each 10-15 minute periods when the gas mixtures are administered. This will usually be 4-6 hours after the sleep study has started.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Alteration in the pattern of breathing during exposure to simulated high altitude during sleep</outcome>
      <timepoint>During each 10-15 minute period when the gas mix is administered during overnight sleep study. This will usually be between 4 and 6 hours after the study starts.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Moderate severity obstructive sleep apnoea.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Coexistent significant other organ disease. Desaturation below 65% at sea level.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subjects are enrolled prior to the first study night.They are allocated on the first study night by the toss of a coin  to either of the two study arms.</concealment>
    <sequence>Toss of a coin is used to determine which is the initial study condition</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/08/2007</anticipatedstartdate>
    <actualstartdate>1/08/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate>26/10/2007</actualenddate>
    <samplesize>10</samplesize>
    <actualsamplesize>6</actualsamplesize>
    <recruitmentstatus>Terminated</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>2095</postcode>
    <postcode>2086</postcode>
    <postcode>2096</postcode>
    <postcode>2099</postcode>
    <postcode>2083</postcode>
    <postcode>2083</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr K R Burgess</primarysponsorname>
    <primarysponsoraddress>Unit 2/Building 7, 49  Frenchs Forest Road
Frenchs Forest
NSW 2086</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Peninsula Health Care P/L</fundingname>
      <fundingaddress>PO Box 551
Balgaowlah
NSW 2083</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Dr K R Burgess</fundingname>
      <fundingaddress>Unit 2/ Building 7, 49 Frenchs Forest Road
Frenchs Forest
NSW 2086</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>There is no update to the original ethics submission</summary>
    <trialwebsite />
    <publication>Burgess KR, Saye P, Cheong M, Lee CS, Worthington JM. Upper airway resistance in OSA patients during exposure to simulated high altitude. American Thoracic Society International Conference, Toronto 2008.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern Sydney Central Coast AHS</ethicname>
      <ethicaddress>Vinden House
Royal North Shore Hospital Campus
St. Leonards.
NSW</ethicaddress>
      <ethicapprovaldate>16/07/2006</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Keith Burgess</name>
      <address>A/A</address>
      <phone>02 99754911</phone>
      <fax>02 99754622</fax>
      <email>krburgess@optusnet.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Dr K R Burgess</name>
      <address>Level 2, Building 1, 49 Frenchs Forest Road
Frenchs Forest. NSW 2086</address>
      <phone>02 99754911</phone>
      <fax>02 99754622</fax>
      <email>krburgess@optusnet.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Keith Burgess</name>
      <address />
      <phone />
      <fax>02 99754622</fax>
      <email>krburgess@optusnet.com.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Keith Burgess</name>
      <address>Level 2, Building 1, 49 Frenchs Forest Road,
Frenchs Forest NSW 2086</address>
      <phone>+61 2 99754911</phone>
      <fax />
      <email>krburgess@optusnet.com.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>